One of the major driver genes in cancer is a receptor-type tyrosine kinase (RTK), epidermal growth factor receptor (EGFR), and persistent growth factor receptor signaling including that from EGFR activates mechanistic target of rapamycin (mTOR) complex signaling, potentially affecting protein PTMs including acetylation [116]. Here, EGFR is linked to cancer.